Oncology/Hematology > Prostate Cancer — Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients by Charles Bankhead, Senior Editor, MedPage Today February 16, 2024….
Satisfying Coverage > GICS — Lutetium dotatate decreases PFS danger by 72% in randomized trial by Charles BankheadSenior Editor, MedPage Today January 20, 2024 SAN FRANCISCO– Adding a radioligand to….